2024 |
Stoke Therapeutics Inc
|
Chief Financial Officer and Principal Accounting Officer |
- |
- |
2023 |
Stoke Therapeutics Inc
|
Chief Financial Officer and Principal Accounting Officer |
1.6 M |
-31.0 % |
2022 |
Stoke Therapeutics Inc
|
Chief Financial Officer and Principal Accounting Officer |
2.3 M |
-25.3 % |
2021 |
Stoke Therapeutics Inc
|
- |
3.1 M |
69.8 % |
2021 |
Stoke Therapeutics Inc
|
Chief Financial Officer and Principal Accounting Officer |
3.1 M |
69.8 % |
2020 |
Stoke Therapeutics Inc
|
- |
1.8 M |
55.3 % |
2020 |
Stoke Therapeutics Inc
|
- |
1.8 M |
55.3 % |
2020 |
Stoke Therapeutics Inc
|
Chief Financial Officer and Principal Accounting Officer |
1.8 M |
55.3 % |
2019 |
Stoke Therapeutics Inc
|
- |
1.2 M |
- |
2019 |
Stoke Therapeutics Inc
|
- |
1.2 M |
- |
2019 |
Stoke Therapeutics Inc
|
Chief Financial Officer and Principal Accounting Officer |
1.2 M |
- |
2018 |
Stoke Therapeutics Inc
|
Chief Financial Officer |
- |
- |